Phase II Study of Pandemic Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
- Status
- COMPLETED
- Phase
- PHASE2
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958
- Status
- COMPLETED
- Phase
- PHASE1
Chart Review of Antivirals for Influenza in Infants
- Status
- COMPLETED
- Phase
- N/A
St. Jude Open Label H5 Trial
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)
- Status
- COMPLETED
- Phase
- PHASE3
H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years
- Status
- COMPLETED
- Phase
- PHASE1
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
- Status
- COMPLETED
- Phase
- PHASE2
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™
- Status
- COMPLETED
- Phase
- N/A
Annual Study for Fluarix Registration
- Status
- COMPLETED
- Phase
- PHASE3